Effects of flumazenil (Ro15-1788) on blood glucose and serum lipids in normoglycemic and normolipidemic rats.
The intraperitoneal administration of flumazenil, an imidazoldiazepine with selective antagonistic properties on the central benzodiazepine receptors, induced in normoglycemic-normolipidemic rats a significant increase in blood glucose levels and significant decreases in the serum lipids.
Horák
J
J
Cuparencu
B
B
D000818:Animals; D001786:Blood Glucose / Q000187:drug effects*; D005442:Flumazenil / Q000008:administration & dosage / Q000494:pharmacology*; D007274:Injections, Intraperitoneal; D008055:Lipids / Q000097:blood*; D008297:Male; D051381:Rats; D017208:Rats, Wistar
D001786:Blood Glucose; D008055:Lipids; D005442:Flumazenil